7341 results
Keyword Sildenafil Germed Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Sildenafil ratiopharm (updated)
sildenafil, Erectile Dysfunction
Date of authorisation: 23/12/2009,
, Revision: 19, Authorised, Last updated: 24/06/2022
Sildenafil ratiopharm Male Urogenital … Authorised sildenafil Overview This is a summary … assessment report (EPAR) for sildenafil. It explains how the The committee … -
List item
Human medicine European public assessment report (EPAR): Sildenafil Actavis (updated)
sildenafil, Erectile Dysfunction
Date of authorisation: 10/12/2009,, Revision: 15, Authorised, Last updated: 28/06/2022
Sildenafil Actavis Male Urogenital … Authorised sildenafil Overview This is a summary … part of the EPAR). What is Sildenafil Actavis Sildenafil Actavis is a medicine that … -
List item
Human medicine European public assessment report (EPAR): Sildenafil Teva
sildenafil, Erectile Dysfunction
Date of authorisation: 30/11/2009,, Revision: 16, Authorised, Last updated: 26/10/2021
Sildenafil Teva Male Urogenital Diseases Genital … Authorised sildenafil Overview This is a summary … assessment report (EPAR) for Sildenafil Teva. It explains how the … -
List item
Withdrawn application: Sildenafil FGK
sildenafil, date of withdrawal: 19/07/2021, Initial authorisation, Last updated: 05/10/2021Sildenafil FGK: Withdrawn application … marketing authorisation of Sildenafil FGK sildenafil) FGK Representative Service … marketing authorisation of Sildenafil FGK for the treatment of … -
List item
Human medicine European public assessment report (EPAR): Granpidam
sildenafil citrate, Hypertension, Pulmonary
Date of authorisation: 14/11/2016,, Revision: 6, Authorised, Last updated: 21/12/2021
sildenafil … Granpidam, INN: sildenafil EMA/622310/2016 EMEA/H/C/004289 … for the public Granpidam sildenafil This is a summary of the … -
List item
Human medicine European public assessment report (EPAR): Revatio (updated)
sildenafil, Hypertension, Pulmonary
Date of authorisation: 28/10/2005, Revision: 47, Authorised, Last updated: 21/06/2022Authorised sildenafil Overview This is a summary … medicine. active substance sildenafil. How is Revatio used? Revatio … active substance in Revatio, sildenafil, belongs to a group of medicines … -
List item
Human medicine European public assessment report (EPAR): Viagra
sildenafil, Erectile Dysfunction
Date of authorisation: 13/09/1998, Revision: 40, Authorised, Last updated: 08/03/2022Authorised sildenafil Overview This is a summary … medicine. active substance sildenafil. It is available as tablets … active ingredient in Viagra, sildenafil, belongs to a group of medicines … -
List item
Human medicine European public assessment report (EPAR): Mysildecard
sildenafil citrate, Hypertension, Pulmonary
Date of authorisation: 15/09/2016,, Revision: 5, Authorised, Last updated: 12/01/2022
Authorised sildenafil Overview This is a summary … medicine. active substance sildenafil. It is a ‘ A generic medicine … other medicines containing sildenafil should therefore be used … -
List item
Human medicine European public assessment report (EPAR): Vizarsin
sildenafil, Erectile Dysfunction
Date of authorisation: 21/09/2009,, Revision: 17, Authorised, Last updated: 12/01/2022
Authorised sildenafil Overview This is a summary … medicine. active substance sildenafil. It is available as film-coated … active ingredient in Vizarsin, sildenafil, belongs to a group of medicines … -
List item
Human medicine European public assessment report (EPAR): Patrex
sildenafil, Erectile Dysfunction
Date of authorisation: 15/09/1998, Revision: 4, Withdrawn, Last updated: 18/08/2005Withdrawn sildenafil Overview The marketing authorisation … Public statement on Patrex (sildenafil): Non-renewal of the marketing … PUBLIC STATEMENT ON PATREX (sildenafil) NON-RENEWAL OF THE … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): Revatio, sildenafil
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Other
PIP number: EMEA-000671-PIP01-09-M10, Route(s) of administration: Oral use, Intravenous use, Pharmaceutical form(s): Film-coated tablet, Powder for oral solution, Solution for injection
Decision date: 03/01/2019, Last updated: 21/09/2021, Compliance check: V, 20/09/2019Revatio Active substance sildenafil Therapeutic area Other Decision … Revatio Revatio sildenafil sildenafil sildenafil … -
List item
Withdrawn application: Viagra
sildenafil, date of withdrawal: 19/11/2008, Post-authorisation, Last updated: 20/11/2008contains the active substance sildenafil. It is available as tablets … active ingredient in Viagra, sildenafil, belongs to a group of medicines … International Nonproprietary Name: Sildenafil citrate Procedure No … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): gallium (68Ga) chloride, germanium (68Ge) chloride
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Other
PIP number: EMEA-001102-PIP01-10, Route(s) of administration: Other use, Pharmaceutical form(s): Radionuclide generator
Decision date: 08/06/2011, Last updated: 14/07/2011, Compliance check: Xfacts gallium (68Ga) chloride germanium (68Ge) chloride OtherP/133/2011EMEA-001102-PIP01-10 … regaffairs.radiopharma@ezag.de Germany +49 30941084282 +49 30941084160 … Gallium [68 Ga] Chloride / Germanium [68 Ge] Chloride (EMEA-001102-PIP01-10 … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): germanium (68Ge) chloride, gallium (68Ga) chloride
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Other
PIP number: EMEA-002436-PIP01-18, Pharmaceutical form(s): Radionuclide generator
Decision date: 03/01/2019, Last updated: 24/04/2019, Compliance check: XKey facts germanium (68Ge) chloride gallium (68Ga … product specific waiver for Germanium (68Ge) chloride / Gallium … germanium (68Ge) chloride gallium … -
List item
Orphan designation: sildenafil for: Treatment of congenital diaphragmatic hernia
Date of designation: 20/06/2017, Positive, Last updated: 17/07/2017sildenafil Overview On 20 June 2017 … BV, the Netherlands, for sildenafil for the treatment of congenital … medicine expected to work? Sildenafil is expected to be given during … -
List item
Orphan designation: sildenafil citrate for: treatment of postcardiotomy right ventricular failure
Date of designation: 26/11/2010, Positive, Last updated: 23/10/2018sildenafil citrate Overview On 26 November … Limited, United Kingdom, for sildenafil citrate for the treatment … medicine expected to work? Sildenafil is a medicine that has been … -
List item
Orphan designation: sildenafil citrate for: Treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Date of designation: 12/12/2003, Expired, Last updated: 19/01/2016sildenafil citrate Overview Please note … Limited, United Kingdom, for sildenafil citrate for the treatment … thromboembolic pulmonary hypertension. Sildenafil citrate has been authorised … -
List item
Human medicine European public assessment report (EPAR): Bavencio
avelumab, Neuroendocrine Tumors
Date of authorisation: 18/09/2017,
, Revision: 12, Authorised, Last updated: 26/04/2022
ctodermal Tumors Neoplasms, Germ Cell and Embryonal Neoplasms … -
List item
Human medicine European public assessment report (EPAR): Gliolan (updated)
5-aminolevulinic acid hydrochloride, Glioma
Date of authorisation: 07/09/2007, Revision: 6, Authorised, Last updated: 15/06/2022Neuroepithelial Neuroectodermal Tumors Neoplasms, Germ Cell and Embryonal Neoplasms … PDF/46.94 KB) (PDF/46.94 KB) German (PDF/47.08 KB) (PDF/47.08 … -
List item
Human medicine European public assessment report (EPAR): Temozolomide Hexal (updated)
temozolomide, Glioma; Glioblastoma
Date of authorisation: 15/03/2010,, Revision: 17, Authorised, Last updated: 30/05/2022
Hexal Cancer Neuroectodermal Tumors Neoplasms, Germ Cell and Embryonal Neoplasms Neoplasms … Industriestrasse 25 D-83607 Holzkirchen Germany Product information 24/05/2022 … -
List item
Human medicine European public assessment report (EPAR): Temozolomide Sandoz (updated)
temozolomide, Glioma; Glioblastoma
Date of authorisation: 15/03/2010,, Revision: 17, Authorised, Last updated: 30/05/2022
Sandoz Cancer Neuroectodermal Tumors Neoplasms, Germ Cell and Embryonal Neoplasms Neoplasms … -
List item
Human medicine European public assessment report (EPAR): Mekinist
trametinib, Melanoma
Date of authorisation: 30/06/2014, Revision: 27, Authorised, Last updated: 05/05/2022Tumors Neuroectodermal Tumors Neoplasms, Germ Cell and Embryonal Nevi … PDF/108.53 KB) (PDF/108.53 KB) German (PDF/108.29 KB) (PDF/108.29 … -
List item
Human medicine European public assessment report (EPAR): Lutathera
lutetium (177Lu) oxodotreotide, Neuroendocrine Tumors
Date of authorisation: 26/09/2017,, 
, Revision: 6, Authorised, Last updated: 10/05/2022
ancer Neoplasms Neoplasms, Germ Cell and Embryonal Neuroectodermal … -
List item
Human medicine European public assessment report (EPAR): Imlygic
talimogene laherparepvec, Melanoma
Date of authorisation: 16/12/2015, Revision: 11, Authorised, Last updated: 21/04/2022Tissue Neoplasms Cancer Neoplasms, Germ Cell and Embryonal Nevi … PDF/78.96 KB) (PDF/78.96 KB) German (PDF/79.47 KB) (PDF/79.47 … -
List item
Human medicine European public assessment report (EPAR): Temomedac
temozolomide, Glioma; Glioblastoma
Date of authorisation: 25/01/2010,, Revision: 15, Authorised, Last updated: 28/03/2022
ctodermal Tumors Neoplasms, Germ Cell and Embryonal Neoplasms Neoplasms … PDF/86.89 KB) (PDF/86.89 KB) German (PDF/85.23 KB) (PDF/85.23 …